Total Funding
22
43
Total FundingVenture - Series Unknown raised
Growth Score 22 in past quarter
-7 pts
Heat Score 43 in past quarter
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
65530
CoreRx™ offers comprehensive drug product development services to the pharmaceutical and biotechnology industries. Supporting virtual.
Acquired by 
Novaquest Capital Management
- Bill Reid: Executive Director & Chief Operations OfficerPast Role: Xcelience, Sr. Project Manager
- Bob Berg: Chief Financial OfficerPast Role: West-Ward Pharmaceuticals, VP & Chief Financial Officer
About the Company
CoreRx™ is a contract pharmaceutical development organization that helps get products into the clinic faster, providing a complete spectrum of cGMP solutions for pharmaceutical dosage form development. Our wide range of support services, extensive instrumentation and rigorous quality systems provide timely results communicated in a clear, efficient
and consistent manner.

